| Outcomes of nevirapine-and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy A Boulle, G Van Cutsem, K Cohen, K Hilderbrand, S Mathee, M Abrahams, ... Jama 300 (5), 530-539, 2008 | 279 | 2008 |
| Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CR Swanepoel, MG Atta, VD D’Agati, MM Estrella, AB Fogo, S Naicker, ... Kidney international 93 (3), 545-559, 2018 | 214 | 2018 |
| Antiretroviral therapy and early mortality in South Africa A Boulle, P Bock, M Osler, K Cohen, L Channing, K Hilderbrand, ... Bulletin of the World Health Organization 86 (9), 678-687, 2008 | 197 | 2008 |
| Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction R de Waal, K Cohen, G Maartens PloS one 8 (5), e63623, 2013 | 134 | 2013 |
| Therapeutic drug monitoring of antiretrovirals for people with HIV T Kredo, JS Van der Walt, N Siegfried, K Cohen Cochrane Database of Systematic Reviews, 2009 | 129 | 2009 |
| Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections R Gounden, C Bamford, R van Zyl-Smit, K Cohen, G Maartens BMC infectious diseases 9, 1-6, 2009 | 128 | 2009 |
| Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis K Cohen, G van Cutsem, A Boulle, H McIlleron, E Goemaere, PJ Smith, ... Journal of antimicrobial chemotherapy 61 (2), 389-393, 2008 | 118 | 2008 |
| Management of individuals requiring antiretroviral therapy and TB treatment K Cohen, G Meintjes Current Opinion in HIV and AIDS 5 (1), 61-69, 2010 | 116 | 2010 |
| Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G> T polymorphism on efavirenz concentrations in adults in South Africa K Cohen, A Grant, C Dandara, H McIlleron, L Pemba, K Fielding, ... Antiviral therapy 14 (5), 687-695, 2009 | 116 | 2009 |
| Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross‐sectional survey JP Mouton, U Mehta, AG Parrish, DPK Wilson, A Stewart, CW Njuguna, ... British journal of clinical pharmacology 80 (4), 818-826, 2015 | 114 | 2015 |
| A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy C Orrell, K Cohen, K Mauff, DR Bangsberg, G Maartens, R Wood JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (5), 495-502, 2015 | 109 | 2015 |
| Provision of antiretroviral therapy in South Africa: the nuts and bolts LG Bekker, F Venter, K Cohen, E Goemare, G Van Cutsem, A Boulle, ... Antiviral therapy 19 (3_suppl), 105-116, 2014 | 102 | 2014 |
| Adverse drug reactions causing admission to medical wards: a cross-sectional survey at 4 hospitals in South Africa JP Mouton, C Njuguna, N Kramer, A Stewart, U Mehta, M Blockman, ... Medicine 95 (19), e3437, 2016 | 99 | 2016 |
| N‐acetylcysteine for non‐paracetamol drug‐induced liver injury: a systematic review MF Chughlay, N Kramer, CW Spearman, M Werfalli, K Cohen British Journal of Clinical Pharmacology 81 (6), 1021-1029, 2016 | 80 | 2016 |
| Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes? C Orrell, K Cohen, R Leisegang, DR Bangsberg, R Wood, G Maartens AIDS Research and Therapy 14, 1-11, 2017 | 77 | 2017 |
| Risk factors for incident diabetes in a cohort taking first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy S Karamchand, R Leisegang, M Schomaker, G Maartens, L Walters, ... Medicine 95 (9), e2844, 2016 | 76 | 2016 |
| Antiretroviral therapy in a community clinic-early lessons from a pilot project L Bekker, C Orrell, L Reader, K Matoti, K Cohen, R Martell, F Abdullah, ... South African Medical Journal 93 (6), 458-462, 2003 | 76 | 2003 |
| Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries G Maartens, E Decloedt, K Cohen Antiviral therapy 14 (8), 1039-1043, 2009 | 75 | 2009 |
| Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients T Kredo, K Mauff, JS Van der Walt, L Wiesner, G Maartens, K Cohen, ... Antimicrobial agents and chemotherapy 55 (12), 5616-5623, 2011 | 71 | 2011 |
| Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug … V Johnston, K Cohen, L Wiesner, L Morris, J Ledwaba, KL Fielding, ... The Journal of infectious diseases 209 (5), 711-720, 2014 | 56 | 2014 |
Andrew BoulleSchool of Public Health and Family Medicine, University of Cape TownVerified email at uct.ac.za
